PubRank

J Hirschowitz

Author PubWeight™ 18.90‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Further evidence of a dose-response threshold for haloperidol in psychosis. Am J Psychiatry 1995 2.05
2 Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia. Psychiatry Res 1993 1.07
3 The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy. J Clin Psychiatry 1985 0.93
4 Morning amnestic effects of triazolam. Hillside J Clin Psychiatry 1986 0.86
5 Clinical characteristics of Kraepelinian schizophrenia: replication and extension of previous findings. Am J Psychiatry 1996 0.83
6 Lithium response in good prognosis schizophrenia. Am J Psychiatry 1980 0.82
7 Membrane abnormalities in the psychoses and affective disorders. J Psychiatr Res 1984 0.81
8 Drug response patterns as a basis of nosology for the mood-incongruent psychoses (the schizophrenias). Psychol Med 1988 0.81
9 Early response to haloperidol treatment in chronic schizophrenia. Schizophr Res 1993 0.80
10 Clinical response and plasma haloperidol levels in schizophrenia. Psychopharmacology (Berl) 1983 0.79
11 Relation of clinical symptoms to apomorphine-stimulated growth hormone release in mood-incongruent psychotic patients. Arch Gen Psychiatry 1986 0.79
12 Lithium transport in human fibroblasts: relationship to RBC lithium transport and psychiatric diagnoses. Psychiatry Res 1988 0.77
13 Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale. Biol Psychiatry 1996 0.77
14 Nocturnal growth hormone secretion in schizophrenic patients and healthy subjects. Psychiatry Res 1992 0.77
15 Physostigmine and lithium response in the schizophrenias. Am J Psychiatry 1981 0.76
16 Growth hormone response to apomorphine and family patterns of illness. Biol Psychiatry 1987 0.76
17 Growth hormone response to apomorphine and diagnosis: a comparison of three diagnostic systems. Biol Psychiatry 1986 0.76
18 Clonazepam treatment of five lithium-refractory patients with bipolar disorder. Am J Psychiatry 1989 0.76
19 Haloperidol plasma and red blood cell levels and clinical antipsychotic response. J Clin Psychopharmacol 1984 0.76
20 Impact of lithium therapy on core psychotic symptoms of schizophrenia. Br J Psychiatry 1984 0.76
21 Single- vs multiple-dose pharmacokinetics of clozapine in psychiatric patients. Pharm Res 1990 0.75
22 SPECT studies of D2 occupancy in low-dose haloperidol treatment. Am J Psychiatry 1997 0.75
23 Thioridazine effect on desipramine plasma levels. J Clin Psychopharmacol 1983 0.75
24 Membranes, methylation and lithium responsive psychoses. Nutr Health 1984 0.75
25 RBC lithium transport in the psychoses. Biol Psychiatry 1989 0.75
26 Fluphenazine plasma levels and clinical response. J Clin Psychiatry 1984 0.75
27 On the physical properties of red cell ghost membranes in the affective disorders and psychoses. A fluorescence polarization study. J Affect Disord 1986 0.75
28 Side effects of cyproheptadine. Br Med J 1978 0.75
29 Platelet monoamine oxidase activity in the psychoses: relationship to symptoms and lithium response. Psychiatry Res 1984 0.75
30 Compulsory treatment of 50 alcoholic drunken drivers. A follow-up study. S Afr Med J 1983 0.75
31 Plasma haloperidol levels and clinical response: confounding variables. Psychopharmacol Bull 1985 0.75
32 Danazol and thyroid function. Ann Intern Med 1979 0.75
33 Down-regulation of central dopamine receptors in schizophrenia. Am J Psychiatry 1985 0.75
34 Mood-incongruent versus mood-congruent psychosis: differential antipsychotic response to lithium therapy. Psychiatry Res 1984 0.75
35 Comparative effects of limbitrol and amitriptyline on sleep efficiency and architecture. J Clin Psychiatry 1986 0.75
36 Therapeutic blood levels of fluphenazine: plasma or RBC determinations? Psychopharmacol Bull 1984 0.75
37 Lack of amnestic effects of clorazepate on geriatric recall. J Clin Psychiatry 1985 0.75
38 Cyproheptadine in the management of the galactorrhea-amenorrhea syndrome. Ann Intern Med 1979 0.75
39 Combined thioridazine and desipramine: early antidepressant response. Psychopharmacology (Berl) 1984 0.75
40 Possible efficacy of alprazolam in restless leg syndrome. Hillside J Clin Psychiatry 1986 0.75
41 Kinetic analysis of platelet monoamine oxidase in chronic schizophrenia. Life Sci 1981 0.75
42 Characteristics of phospholipid methylation in human erythrocyte ghosts: relationship(s) to the psychoses and affective disorders. Biol Psychiatry 1985 0.75
43 Fluphenazine activity and antipsychotic response. Psychopharmacology (Berl) 1986 0.75
44 Effect of haloperidol dose on iodine-123-IBZM brain SPECT imaging in schizophrenic patients. J Nucl Med 1997 0.75
45 Clinical relevance of thiothixene plasma levels. J Clin Psychopharmacol 1984 0.75
46 The prolactin response in schizophrenic, schizophreniform, and manic disorders. Biol Psychiatry 1984 0.75
47 Growth hormone levels and lithium ratios as predictors of success of lithium therapy in schizophrenia. Am J Psychiatry 1982 0.75
48 Dopamine and non-dopamine psychoses. Psychopharmacology (Berl) 1984 0.75
49 Predictors of response to lithium in patients with psychoses. Am J Psychiatry 1995 0.75
50 Relationship of psychotic symptom clusters in schizophrenia to neuroleptic treatment and growth hormone response to apomorphine. Psychiatry Res 1986 0.75
51 On the relation between platelet monoamine oxidase activity and the growth hormone response in psychosis. Biol Psychiatry 1983 0.75
52 The usefulness of desipramine blood level monitoring: a case report. J Clin Psychopharmacol 1982 0.75
53 Lithium ratio in vitro. Diagnosis and lithium carbonate response in psychotic patients. Arch Gen Psychiatry 1984 0.75
54 Lithium response and psychoses: a double-blind, placebo-controlled study. Psychiatry Res 1984 0.75